GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Awakn Life Sciences Corp (OTCPK:AWKNF) » Definitions » Change In Receivables

AWKNF (Awakn Life Sciences) Change In Receivables : $0.18 Mil (TTM As of Jul. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Awakn Life Sciences Change In Receivables?

Awakn Life Sciences's change in receivables for the quarter that ended in Jul. 2024 was $-0.00 Mil. It means Awakn Life Sciences's Accounts Receivable increased by $0.00 Mil from Apr. 2024 to Jul. 2024 .

Awakn Life Sciences's change in receivables for the fiscal year that ended in Jan. 2024 was $0.06 Mil. It means Awakn Life Sciences's Accounts Receivable declined by $0.06 Mil from Jan. 2023 to Jan. 2024 .

Awakn Life Sciences's Accounts Receivable for the quarter that ended in Jul. 2024 was $0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Awakn Life Sciences's Days Sales Outstanding for the three months ended in Jul. 2024 was 22.81.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Awakn Life Sciences's liquidation value for the three months ended in Jul. 2024 was $-1.27 Mil.


Awakn Life Sciences Change In Receivables Historical Data

The historical data trend for Awakn Life Sciences's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Awakn Life Sciences Change In Receivables Chart

Awakn Life Sciences Annual Data
Trend Jan21 Jan22 Jan23 Jan24
Change In Receivables
- -0.07 - 0.06

Awakn Life Sciences Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.10 -0.05 0.24 -0.01 -

Awakn Life Sciences Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jul. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.18 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Awakn Life Sciences  (OTCPK:AWKNF) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Awakn Life Sciences's Days Sales Outstanding for the quarter that ended in Jul. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0.002/0.008*91
=22.81

2. In Ben Graham's calculation of liquidation value, Awakn Life Sciences's accounts receivable are only considered to be worth 75% of book value:

Awakn Life Sciences's liquidation value for the quarter that ended in Jul. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=0.52-1.795+0.75 * 0.002+0.5 * 0
=-1.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Awakn Life Sciences Change In Receivables Related Terms

Thank you for viewing the detailed overview of Awakn Life Sciences's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Awakn Life Sciences Business Description

Traded in Other Exchanges
Address
301?217 Queen Street West, Toronto, ON, CAN, M5V 0R2
Awakn Life Sciences Corp is a clinical-stage biotechnology company intended to develop therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder. The Company focuses on Alcohol Use Disorder (AUD), a condition affecting people in the US and key international markets and many people globally for which the current standard of care is inadequate, enabling it to provide breakthrough therapeutics to addiction sufferers in desperate need.

Awakn Life Sciences Headlines